Genpact director granted 6,521 restricted share units

Conigliaro Laura reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Conigliaro Laura reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Laura Conigliaro received an equity award of 6,521 unvested restricted share units (RSUs). The grant was made in the form of common share RSUs under the Genpact Limited 2017 Omnibus Incentive Compensation Plan as part of her director compensation.

Each RSU entitles her to receive one common share at a future date. The RSUs are scheduled to fully vest on December 31, 2026, assuming she continues in service, and will be settled in common shares on December 31, 2027. Following this grant, she directly holds 79,337 common shares.

Insider Trade Summary

Grant/Award: 6,521 shares

Grant/Award 1 txn

Insider Conigliaro Laura

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,521	$0.00	$0.00

Holdings After Transaction: Common Shares — 79,337 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Key Figures

RSU award size: 6,521 units Grant price: $0.0000 per share Shares held after grant: 79,337 shares +2 more

5 metrics

RSU award size 6,521 units Unvested restricted share units granted to director

Grant price $0.0000 per share Stock-based compensation, not open-market purchase

Shares held after grant 79,337 shares Direct Genpact common share holdings post-award

RSU vesting date December 31, 2026 Full vesting subject to continued service

RSU settlement date December 31, 2027 RSUs settled in Genpact common shares

Key Terms

restricted share units (RSUs), Omnibus Incentive Compensation Plan, vest, settled in common shares

4 terms

restricted share units (RSUs) financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

Omnibus Incentive Compensation Plan financial

"granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

An omnibus incentive compensation plan is a single, flexible program that lets a company grant different kinds of pay — such as cash bonuses, stock options, restricted stock, or performance awards — to employees, executives and directors. Investors care because the plan affects how much ownership can be given away (dilution), how much the company spends on pay, and whether executives’ goals are aligned with shareholders, much like a menu that decides what rewards staff can pick and how costly they are.

vest financial

"the RSUs will fully vest on December 31, 2026 and will be settled in common shares"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settled in common shares financial

"will be settled in common shares on December 31, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genpact (G) report for Laura Conigliaro?

Genpact reported that director Laura Conigliaro received an award of 6,521 unvested restricted share units. These RSUs are a form of stock-based compensation, not an open-market share purchase, and increase her direct equity exposure to Genpact through future share settlement.

How many Genpact shares does Laura Conigliaro hold after this RSU grant?

After the RSU grant, Laura Conigliaro directly holds 79,337 Genpact common shares. This figure includes the impact of the 6,521 newly awarded restricted share units, which will convert into common shares when they vest and later settle, assuming continued service.

When do Laura Conigliaro’s new Genpact RSUs vest and settle?

The 6,521 restricted share units granted to Laura Conigliaro will fully vest on December 31, 2026, subject to her continued service. The RSUs are scheduled to be settled in Genpact common shares on December 31, 2027, turning the units into actual tradable shares.

What type of equity award did Genpact grant to director Laura Conigliaro?

Genpact granted Laura Conigliaro an award of 6,521 unvested restricted share units under its 2017 Omnibus Incentive Compensation Plan. Each RSU represents the right to receive one Genpact common share at a future date, aligning director compensation with shareholder interests over time.

Is Laura Conigliaro’s Genpact RSU award an open-market share purchase?

No, the 6,521 Genpact RSUs awarded to Laura Conigliaro are not an open-market share purchase. They are a stock-based compensation grant with a zero dollar grant price, vesting over time and converting into common shares on specified future dates, subject to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conigliaro Laura

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/23/2026		A		6,521(1)	A	$0	79,337	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Laura Conigliaro	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)